 ?您的位置：對照品 > 對照品 > 雜質對照品 > |
|
|
|
| 產品基本信息 |
|
| 產品編號：B410845 |
| 產品名稱：4-(5-(Bis(2-(benzyloxy)ethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid |
| 產品CAS： |
| 規格含量：500mg |
| 產品價格：面議 |
| 聯系我們: |
 |
|
 |
|
|
| 產品詳細介紹 |
| 標準品編號: |
B410845 |
| 名稱: |
4-(5-(Bis(2-(benzyloxy)ethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid |
| 分子式: |
C??H??N?O? |
| 外觀： |
白色固體 |
| 分子量: |
501.62 |
| 溶解度: |
Chloroform, DCM |
| 類別: |
Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
4-(5-(Bis(2-(benzyloxy)ethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid is an intermediate in the synthesis of Bendamustine (B132500), an anticancer drug. |
| 文獻 |
|
|
|
|
|
|
![4-(5-(Bis(2-(benzyloxy)ethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid](/images/defaultpic.gif "4-(5-(Bis(2-(benzyloxy)ethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid")
